Research indicates that experimental HIV vaccination regimens are probably not going to be very successful in preventing HIV acquisition.

Published Date: 13 Dec 2023

The HIV prevention study known as PrEPVacc, which involved 1,500 volunteer participants in East and Southern Africa and involved experimental vaccine regimens and a novel oral pre-exposure prophylaxis (PrEP), has halted.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belgian Algorithm Reshapes Endometrial Cancer Care

2.

ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer

3.

Nuclear missile workers are contracting cancer: They blame the bases

4.

On all CAR-T products, the FDA is calling for a new boxed warning.

5.

ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot